查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469858

全球心臟幫浦設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Heart Pump Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

全球心泵設備市場需求預計將從 2023 年的 39.2 億美元達到近 203.6 億美元的市場規模，2024 年至 2032 年的研究期間複合年成長率為 20.09%。

心臟幫浦裝置，也稱為心室輔助裝置 (VAD) 或機械循環支援裝置，用於替代或支持衰竭心臟的功能。它通常透過手術植入，幫助心臟將血液泵送到全身，減輕心臟衰竭症狀並改善血液循環。它可以用作心臟移植的橋樑，作為不適合移植的個體的目標治療，或作為心臟手術恢復期間的臨時支持措施。

市場動態

冠狀動脈疾病、心臟衰竭和心肌病等心血管疾病的盛行率不斷增加，加上人口老化和生活方式因素，正在推動對心臟泵設備的需求，將其作為嚴重心臟衰竭患者的救生治療選擇。此外，醫療設備技術的進步，包括小型化、無線連接和感測器整合，使得下一代心臟泵設備的開發能夠提高可靠性、耐用性和患者治療效果。此外，越來越多的人接受機械循環支援裝置，例如全人工心臟（TAH）和心室輔助裝置（VAD）作為終末期心臟衰竭患者的標準護理治療，正在推動市場擴張。

此外，心臟幫浦設備適應症的不斷擴大，包括目的地治療、移植橋和恢復橋，正在擴大適合設備植入的患者群體，並刺激市場成長。此外，擴大採用微創手術技術和經皮植入手術正在擴大治療範圍並推動市場滲透。此外，醫療設備製造商、醫療保健提供者和研究機構之間的策略合作和夥伴關係促進創新並加速先進心臟幫浦技術的開發和商業化。然而，報銷政策的限制和替代療法的競爭可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心臟幫浦設備市場的各個細分市場進行了包容性評估。心臟泵設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心臟幫浦設備市場報告的這一部分提供了國家和地區級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

  • 植入式心臟幫浦裝置
  • 體外心臟幫浦裝置

按產品分類

  • 心室輔助裝置 (VAD)（左心室輔助裝置 (LVAD)、右心室輔助裝置 (RVAD)、雙心室輔助裝置 (Bivad)、經皮心室輔助裝置 (PVAD)）
  • 全人工心臟 (TAH)
  • 主動脈內球囊反搏 (IABP)
  • 體外膜氧合（ECMO）

按最終用途

  • 醫院
  • 心臟中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟泵設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟幫浦設備市場的主要參與者包括 Abbott、Abiomed、CorWave SA、LivaNova PLC、Berlin Heart、SynCardia Systems, LLC、Jarvik Heart、BiVACOR Inc.、Leviticus Cardio、Evaheart, Inc.、Teleflex Incorporated、Getinge AB.、卡馬特(Carmat)、費森尤斯股份公司(Fresenius SE & Co. KgaA)。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：心臟幫浦設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球心臟幫浦設備市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 植入式心臟幫浦裝置
  • 體外心臟幫浦裝置

第 6 章：全球心臟幫浦設備市場分析：依產品

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 心室輔助裝置 (VAD)（左心室輔助裝置 (LVAD)、右心室輔助裝置 (RVAD)、雙心室輔助裝置 (BiVAD)、經皮心室輔助裝置 (PVAD)）
  • 全人工心臟 (TAH)
  • 主動脈內球囊反搏 (IABP)
  • 體外膜氧合（ECMO）

第 7 章：全球心臟幫浦設備市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 心臟中心
  • 其他

第 8 章：全球心臟幫浦設備市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：心臟幫浦設備公司的競爭格局

  • 心泵設備市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abiomed
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CorWave SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • LivaNova PLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Berlin Heart
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • SynCardia Systems LLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Jarvik Heart
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BiVACOR Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Leviticus Cardio
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Evaheart Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teleflex Incorporated
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Getinge AB.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Carmat
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Fresenius SE & Co. KgaA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112114272

The global demand for Heart Pump Device Market is presumed to reach the market size of nearly USD 20.36 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 20.09% under the study period 2024 - 2032.

A heart pump device, also known as a ventricular assist device (VAD) or mechanical circulatory support device, is used to replace or support the function of a failing heart. It is typically implanted surgically and assists the heart in pumping blood throughout the body, alleviating symptoms of heart failure and improving circulation. It can be used as a bridge to heart transplantation, as a destination therapy for individuals ineligible for transplant, or as a temporary support measure during recovery from cardiac surgery.

MARKET DYNAMICS

The increasing prevalence of cardiovascular conditions, such as coronary artery disease, heart failure, and cardiomyopathy, coupled with an aging population and lifestyle factors, is driving the demand for heart pump devices as life-saving treatment options for patients with severe heart failure. Additionally, advancements in medical device technology, including miniaturization, wireless connectivity, and sensor integration, enable the development of next-generation heart pump devices with improved reliability, durability, and patient outcomes. Furthermore, the growing acceptance of mechanical circulatory support devices, such as total artificial hearts (TAHs) and ventricular assist devices (VADs), as standard-of-care treatments for end-stage heart failure patients is driving market expansion.

Moreover, the expanding indications for heart pump devices, including destination therapy, bridge-to-transplantation, and bridge-to-recovery, are widening the patient population eligible for device implantation and stimulating market growth. Additionally, the increasing adoption of minimally invasive surgical techniques and percutaneous implantation procedures is expanding access to treatment and driving market penetration. Furthermore, strategic collaborations and partnerships between medical device manufacturers, healthcare providers, and research institutions foster innovation and accelerate the development and commercialization of advanced heart pump technologies. However, limitations in reimbursement policies and competition from alternative treatments may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of heart pump device. The growth and trends of heart pump device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the heart pump device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Implanted Heart Pump Devices
  • Extracorporeal Heart Pump Devices

By Product

  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (Bivad), Percutaneous Ventricular Assist Devices (PVAD))
  • Total Artificial Hearts (TAHs)
  • Intra-Aortic Balloon Pumps (IABPs)
  • Extracorporeal Membrane Oxygenation (ECMO)

By End-Use

  • Hospitals
  • Cardiac Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Heart Pump Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Heart Pump Device market include Abbott, Abiomed, CorWave SA, LivaNova PLC, Berlin Heart, SynCardia Systems, LLC, Jarvik Heart, BiVACOR Inc., Leviticus Cardio, Evaheart, Inc., Teleflex Incorporated, Getinge AB., Carmat, Fresenius SE & Co. KgaA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HEART PUMP DEVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Type
  • 5.4. Implanted Heart Pump Devices Historic and Forecast Sales By Regions
  • 5.5. Extracorporeal Heart Pump Devices Historic and Forecast Sales By Regions

6. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Product
  • 6.4. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Historic and Forecast Sales By Regions
  • 6.5. Total Artificial Hearts (TAHs) Historic and Forecast Sales By Regions
  • 6.6. Intra-Aortic Balloon Pumps (IABPs) Historic and Forecast Sales By Regions
  • 6.7. Extracorporeal Membrane Oxygenation (ECMO) Historic and Forecast Sales By Regions

7. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End-Use
  • 7.4. Hospitals Historic and Forecast Sales By Regions
  • 7.5. Cardiac Centers Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HEART PUMP DEVICE COMPANIES

  • 9.1. Heart Pump Device Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HEART PUMP DEVICE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Abiomed
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. CorWave SA
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. LivaNova PLC
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Berlin Heart
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. SynCardia Systems LLC
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Jarvik Heart
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. BiVACOR Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Leviticus Cardio
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Evaheart Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Teleflex Incorporated
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Getinge AB.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Carmat
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Fresenius SE & Co. KgaA
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Implanted Heart Pump Devices Market Sales By Geography (USD MN)
  • Extracorporeal Heart Pump Devices Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Market Sales By Geography (USD MN)
  • Total Artificial Hearts (TAHs) Market Sales By Geography (USD MN)
  • Intra-Aortic Balloon Pumps (IABPs) Market Sales By Geography (USD MN)
  • Extracorporeal Membrane Oxygenation (ECMO) Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Heart Pump Device Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Heart Pump Device Report
  • Market Research Process
  • Market Research Methodology
  • Global Heart Pump Device Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Implanted Heart Pump Devices Market Sales By Geography (USD MN)
  • Extracorporeal Heart Pump Devices Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Market Sales By Geography (USD MN)
  • Total Artificial Hearts (TAHs) Market Sales By Geography (USD MN)
  • Intra-Aortic Balloon Pumps (IABPs) Market Sales By Geography (USD MN)
  • Extracorporeal Membrane Oxygenation (ECMO) Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.